Compare CTBI & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTBI | PHAR |
|---|---|---|
| Founded | 1903 | 1988 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 1995 | 2020 |
| Metric | CTBI | PHAR |
|---|---|---|
| Price | $78.50 | $10.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $63.00 | $38.33 |
| AVG Volume (30 Days) | ★ 114.4K | 5.9K |
| Earning Date | 04-15-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | ★ 17.79 | N/A |
| EPS | ★ 1.50 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.02 | $10.04 |
| Revenue Next Year | $4.30 | $2.51 |
| P/E Ratio | ★ $52.08 | $3,041.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $50.25 | $9.62 |
| 52 Week High | $79.59 | $21.34 |
| Indicator | CTBI | PHAR |
|---|---|---|
| Relative Strength Index (RSI) | 69.99 | 21.93 |
| Support Level | $64.34 | N/A |
| Resistance Level | N/A | $17.89 |
| Average True Range (ATR) | 1.80 | 0.47 |
| MACD | 0.24 | -0.33 |
| Stochastic Oscillator | 85.75 | 12.01 |
Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and south-central Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services. The company operates in one reportable segment: community banking services.
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.